Nav Persaud

896 total citations
58 papers, 451 citations indexed

About

Nav Persaud is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Nav Persaud has authored 58 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Economics and Econometrics, 18 papers in Public Health, Environmental and Occupational Health and 14 papers in General Health Professions. Recurrent topics in Nav Persaud's work include Health Systems, Economic Evaluations, Quality of Life (22 papers), Pharmaceutical Economics and Policy (17 papers) and Pharmaceutical Practices and Patient Outcomes (11 papers). Nav Persaud is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (22 papers), Pharmaceutical Economics and Policy (17 papers) and Pharmaceutical Practices and Patient Outcomes (11 papers). Nav Persaud collaborates with scholars based in Canada, United Kingdom and Ireland. Nav Persaud's co-authors include Parvaz Madadi, Frank Sullivan, Steven G. Morgan, Sheryl Spithoff, Jonathon L. Maguire, An‐Wen Chan, Hedyeh Ziai, Karen Tu, Lorenzo Moja and Catherine S. Birken and has published in prestigious journals such as PLoS ONE, PLoS Medicine and The Lancet Infectious Diseases.

In The Last Decade

Nav Persaud

52 papers receiving 439 citations

Peers

Countries citing papers authored by Nav Persaud

Since Specialization

Citations

This map shows the geographic impact of Nav Persaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nav Persaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nav Persaud more than expected).

Fields of papers citing papers by Nav Persaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nav Persaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nav Persaud. The network helps show where Nav Persaud may publish in the future.

Co-authorship network of co-authors of Nav Persaud

This figure shows the co-authorship network connecting the top 25 collaborators of Nav Persaud. A scholar is included among the top collaborators of Nav Persaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nav Persaud. Nav Persaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Voucher for Healthy Foods and Diabetes Control 2025 ·JAMA Internal Medicine ·Nav Persaud, (unknown), (unknown), (unknown), (unknown), Kevin E. Thorpe, Keying Xu, Stephen W. Hwang, Andrew D. Pinto, Enza Gucciardi	0
2	Gender and racialisation of pharmaceutical sector leaders in Canada: a cross-sectional study 2023 ·BMJ Open ·(unknown), (unknown), (unknown), (unknown), Nav Persaud	1
3	Randomized controlled trial evaluating a virtual parenting intervention for young children at risk of obesity: study protocol for Parenting Addressing Early Years Intervention with Coaching Visits in Toronto (PARENT) trial 2023 ·Trials ·Sarah Rae, Jonathon L. Maguire, Mary Aglipay, Melanie Barwick, (unknown), Jess Haines, Jennifer M. Jenkins, (unknown), Myla E. Moretti, Frank S Ong, Nav Persaud, Michelle Porepa, Sharon E. Straus, Erika Tavares, Andrew R. Willan, Catherine S. Birken	2
4	Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO 2022 ·BMJ Open ·Thomas Piggott, Artur Nowak, Romina Brignardello‐Petersen, Graham Cooke, Benedikt Huttner, Holger J. Schünemann, Nav Persaud, Nicola Magrini, Lorenzo Moja	17
5	Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study 2021 ·BMJ Open ·(unknown), Nav Persaud	6
6	Effect of free distribution of medicines on the process of care for adult patients with type 1 and type 2 diabetes and hypertension: post hoc analysis of randomised controlled trial findings 2021 ·BMJ Open ·(unknown), (unknown), (unknown), Braden Manns, Baiju R. Shah, Ri Wang, Nav Persaud	3
7	Recommendations for equitable COVID-19 pandemic recovery in Canada 2021 ·Canadian Medical Association Journal ·Nav Persaud, (unknown), (unknown), (unknown), James R. Dunn, Stephen W. Hwang, Jonathon L. Maguire, Andrew D. Pinto, Patricia O’Campo, Sean B. Rourke, Daniel Werb	15
8	Drivers of the opioid crisis: An appraisal of financial conflicts of interest in clinical practice guideline panels at the peak of opioid prescribing 2020 ·PLoS ONE ·Sheryl Spithoff, Pamela Leece, Frank Sullivan, Nav Persaud, (unknown), (unknown)	26
9	William Osler: saint in a “White man’s dominion” 2020 ·Canadian Medical Association Journal ·Nav Persaud, (unknown), Philip K. Berger	3
10	Withdrawn medicines included in the essential medicines lists of 136 countries 2019 ·PLoS ONE ·(unknown), Igho Onakpoya, (unknown), (unknown), (unknown), Jeffrey K Aronson, Carl Heneghan, Nav Persaud	10
11	Opioid consumption and the inclusion of opioids in 137 national Essential Medicines Lists 2019 ·OSF Preprints (OSF Preprints) ·Carl Heneghan, Jeffrey K Aronson, Nav Persaud, Georgia C. Richards, Constantinos Koshiaris, Kamal R Mahtani	1
12	Exploring the experiences of people in Ontario, Canada who have trouble affording medicines: a qualitative concept mapping study 2019 ·BMJ Open ·(unknown), (unknown), (unknown), (unknown), Patricia O’Campo, Nav Persaud	8
13	Health outcomes related to the provision of free, tangible goods: A systematic review 2019 ·PLoS ONE ·Nav Persaud, (unknown), (unknown), (unknown), Susitha Wanigaratne, Jane Y. Polsky, Stephen W. Hwang, (unknown), Andrew D. Pinto	1
14	Does exposure to simulated patient cases improve accuracy of clinicians’ predictive value estimates of diagnostic test results? A within-subjects experiment at St Michael’s Hospital, Toronto, Canada 2018 ·BMJ Open ·(unknown), Julia Spaniol, Nav Persaud	7
15	Community members co-designing a trial of medication access 2018 ·Canadian Medical Association Journal ·Nav Persaud, (unknown), (unknown)	3
16	Search for unpublished data by systematic reviewers: an audit 2017 ·BMJ Open ·Hedyeh Ziai, (unknown), An‐Wen Chan, Nav Persaud	26
17	Development of a preliminary essential medicines list for Canada 2017 ·CMAJ Open ·(unknown), Haroon Ahmad, Morgan Slater, Babak Aliarzadeh, Richard H. Glazier, Andreas Laupacis, Nav Persaud	16
18	Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada 2017 ·Canadian Medical Association Journal ·Steven G. Morgan, (unknown), (unknown), Nav Persaud	20
19	Toward better prescription drug surveillance in Canada 2016 ·Canadian Medical Association Journal ·Kate Smolina, Nav Persaud, Steven G. Morgan	4
20	North American regulatory agencies can and should make clinical trial data publicly available 2015 ·Canadian Medical Association Journal ·Nav Persaud, Peter Doshi	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact